1
10
1
-
https://d1y502jg6fpugt.cloudfront.net/25425/archive/files/f91cb1a970140143187e049000504485.pdf?Expires=1712793600&Signature=bP3aiLKUKjXFJa3Lws4N%7E4YMPXx-usvwClG-9CTdCvu7%7EeB5e8EgCykrdIPClj9gBF3YVBReeTl9kkWHnAQiJk52x5XN-IXYKiN8WnPd7j9hmhmmAE5tQDh6KlhSlhyOkaEmDYEKroxkA-fmcQ5Zls9KEdOF5k6aZD4AYr6oC3e7Kwtk66EJvdvpLovug0T7F0VwZatygAS65TstvKQgDAVfJUZLWIn0TeyoWA%7E-wo6Vz44OtMWbtJn0CL%7Ex6U5H4X6plR1ssXl3g2eJG6JcxjzvqIP1rAMkrioAGdx-OD6Z30E0%7EvHrmSBymrzB-mE0UTm6%7EtrpAWhieOT5GZhkDQ__&Key-Pair-Id=K6UGZS9ZTDSZM
397458a3683701d2ae63eda0e4e521a3
Website
A resource comprising of a web page or web pages and all related assets ( such as images, sound and video files, etc. ).
Local URL
The URL of the local directory containing all assets of the website
<a href="https://www.trivedieffect.com/science/impact-of-biofield-energy-treated-dmem-on-mitochondrial-biogenesis-using-myoblast-cell-line-c2c12-implications-for-metabolic-disease/">https://www.trivedieffect.com/science/impact-of-biofield-energy-treated-dmem-on-mitochondrial-biogenesis-using-myoblast-cell-line-c2c12-implications-for-metabolic-disease/</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Impact of Biofield Energy Treated DMEM on Mitochondrial Biogenesis Using Myoblast Cell Line, C2C12: Implications for Metabolic Disease
Subject
The topic of the resource
Energy & Fatigue
Description
An account of the resource
<p style="text-align:justify;">Mitochondria play an important role in the body, and its dysfunction lead to the defective cellular energy production results to heterogeneous group of disorders such as early aging, type-2 diabetes, Alzheimer’s disease, and many more metabolic diseases. The study was aimed to examine the effect of Consciousness Energy Healing based DMEM on myoblasts cells (C2C12) for mitochondrial mass content. The test item, DMEM was divided into three parts. First part did not receive any sort of treatment and defined as the untreated DMEM group. The second and third portions were treated with the one-time and two-times Biofield Energy Treatment by a renowned Biofield Energy Healer, Mahendra Kumar Trivedi and coded as the one-time Biofield Energy Treated DMEM (BT-I) and two-times Biofield Energy Treated DMEM (BT-II) groups, respectively. Cell viability of the test items by MTT assay showed more than 72% viable cells, which suggested that the test items were nontoxic and safe in nature. Moreover, the mitochondrial mass content in terms of fluorescence unit (FU) was significantly (p≤0.05) increased by 43.11% and 64.16% in the BT-I and BT-II groups, respectively in C2C12 cells compared to the untreated DMEM group. Overall, the experimental data suggested that two-times treated DMEM (BT-II) was found more significant improvement in mitochondrial mass content compared with the one-time treated DMEM (BT-I) group and results in better respiratory capacity. Thus, data envisaged that the Biofield Energy Treated DMEM has a potential to improve respiratory activity, which could be used against various metabolic diseases, such as insulin resistance, type-2 diabetes, and cardiovascular diseases, etc.</p>
Creator
An entity primarily responsible for making the resource
Mahendra Kumar Trivedi, Snehasis Jana
Publisher
An entity responsible for making the resource available
Medwin Publishers
Date
A point or period of time associated with an event in the lifecycle of the resource
February 19, 2019
Language
A language of the resource
English
Type
The nature or genre of the resource
Journal Article
Identifier
An unambiguous reference to the resource within a given context
10.23880/ijbp-16000146
Biofield Energy
C2C12
DMEM
Metabolic Disorders
Mitochondrial Biogenesis
Myoblast Cell
NAO Assay